Sasser [6] found that the growth rate of MCF-7 estrogen-receptor-positive (ER+) breast carcinoma cells doubled in vitro and increased even more in vivo following treatment with recombinant human IL-6. This evidence concerns the gene ESR1 and breast carcinoma.